Direktorat Registrasi ObatValid

MOXIFLOXACIN HYDROCHLORIDE

Claim this product
BPOM Number
GKL2540312749A1
Approved
7 December 2025
Expiry
6 December 2030
Form
INFUS

About This Registration

MOXIFLOXACIN HYDROCHLORIDE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL2540312749A1. Its current registration status is Valid, with the licence valid until 6 December 2030. The product is registered to NATURA LABORATORIA PRIMA - INDONESIA. BPOM first approved this registration in December 2025. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application
newaero
Packaging
DUS, 20 BOTOL @ 250 ML
Department
Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

Ingredients (1)

MOXIFLOXACIN HYDROCHLORIDE

Market Intelligence

Owner Portfolio
NATURA LABORATORIA PRIMA - INDONESIA holds 91 BPOM registrations
Manufacturer Scale
NATURA LABORATORIA PRIMA - INDONESIA produces 91 registered products
Registration Age
Registered for 8 months

FDA Cross-Reference

via openFDA
Generic Name
MOXIFLOXACIN HYDROCHLORIDE
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product

More products from NATURA LABORATORIA PRIMA - INDONESIA

MOXIFLOXACIN HYDROCHLORIDE

-GKL2540312749A1
Valid
Approved: Dec 6, 2025INFUS
View product →

PIRACETAM

-GKL1240302649A1
Valid
Approved: Nov 13, 2025INFUS
View product →

CEFEPIME HCL MONOHYDRATE

-GKL1140300544A1
Valid
Approved: Sep 30, 2025SERBUK INJEKSI
View product →

LEVOFLOXACIN HEMIHYDRATE

-GKL1640308949A1
Valid
Approved: Sep 25, 2025INFUS
View product →

GABAPENTIN

-GKL1740310001A1
Valid
Approved: Aug 31, 2025KAPSUL
View product →

Products in the same class

TARMESON

-DKL2540505229A1
Valid
Approved: Mar 16, 2026KRIM
BETA PHARMACON - INDONESIA
View product →

GUAIFENESIN

-GTL0307114410A1
Valid
Approved: Aug 1, 2025TABLET
PERUSAHAAN INDUSTRI FARMASI DAN DAGANG FIRST MEDIPHARMA - INDONESIA
View product →

XILERGY

-DTL1413025037A1
Valid
Approved: Jul 18, 2025SIRUP
KONIMEX - INDONESIA
View product →

RIVARIA 15

-DKL2504532617B1
Valid
Approved: Jul 13, 2025TABLET SALUT SELAPUT
DARYA-VARIA LABORATORIA TBK - INDONESIA
View product →

FLAGYL FORTE

-DKL0121200717A1
Valid
Approved: Jul 11, 2025TABLET SALUT SELAPUT
KALVENTIS SINERGI FARMA - INDONESIA
View product →
1